TPCW
CLX icon

TD Private Client Wealth’s Clorox CLX Stock Holding History

TD Private Client Wealth’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.51K Sell
89
-164
-65% -$15.7K ﹤0.01% 1148
2026
Q1 		$26.2K Buy
253
+2
+0.8% +$227 ﹤0.01% 965
2025
Q4 		$25.3K Sell
251
-3
-1% -$326 ﹤0.01% 980
2025
Q3 		$31.3K Sell
254
-3
-1% -$372 ﹤0.01% 924
2025
Q2 		$30.9K Sell
257
-11
-4% -$1.47K ﹤0.01% 924
2025
Q1 		$39.5K Sell
268
-36
-12% -$5.5K ﹤0.01% 842
2024
Q4 		$49.4K Sell
304
-21
-6% -$3.44K ﹤0.01% 820
2024
Q3 		$53K Buy
325
+3
+0.9% +$445 ﹤0.01% 820
2024
Q2 		$44K Sell
322
-284
-47% -$39.4K ﹤0.01% 829
2024
Q1 		$92.8K Sell
606
-272
-31% -$40.6K ﹤0.01% 704
2023
Q4 		$125K Sell
878
-93
-10% -$12.4K ﹤0.01% 642
2023
Q3 		$127K Buy
971
+13
+1% +$1.98K 0.01% 605
2023
Q2 		$152K Sell
958
-14,475
-94% -$2.33M 0.01% 597
2023
Q1 		$2.44M Sell
15,433
-7,182
-32% -$1.08M 0.11% 187
2022
Q4 		$3.17M Buy
22,615
+343
+2% +$48.7K 0.15% 144
2022
Q3 		$2.86M Buy
22,272
+2,581
+13% +$372K 0.15% 145
2022
Q2 		$2.78M Buy
19,691
+9,317
+90% +$1.33M 0.14% 160
2022
Q1 		$1.44M Buy
10,374
+9,921
+2,190% +$1.52M 0.06% 280
2021
Q4 		$79K Sell
453
-54
-11% -$9K ﹤0.01% 673
2021
Q3 		$84K Sell
507
-29
-5% -$4.99K ﹤0.01% 653
2021
Q2 		$96.4K Buy
536
+6
+1% +$1.09K ﹤0.01% 623
2021
Q1 		$102K Sell
530
-68
-11% -$13.1K ﹤0.01% 596
2020
Q4 		$121K Buy
598
+56
+10% +$11.6K 0.01% 533
2020
Q3 		$114K Hold
542
– – 0.01% 517
2020
Q2 		$119K Sell
542
-39
-7% -$7.79K 0.01% 505
2020
Q1 		$101K Buy
581
+10
+2% +$1.65K 0.01% 496
2019
Q4 		$87.7K Buy
+571
New +$85.3K 0.01% 537

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TD Private Client Wealth's CLX Position: Q2 2026 in Review

TD Private Client Wealth reduced its Clorox (CLX) stake by 65% in Q2 2026, selling an estimated $15.7K and leaving 89 shares worth $8.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

TD Private Client Wealth first reported a position in CLX in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.17M in Q4 2022. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • TD Private Client Wealth held 89 shares of Clorox worth $8.51K as of Q2 2026.
  • TD Private Client Wealth sold 164 Clorox shares in Q2 2026, an estimated $15.7K.
  • Clorox made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1148 holding.
  • TD Private Client Wealth first reported a position in Clorox in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Clorox position peaked at $3.17M in Q4 2022.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.